MEG3 and pancreatic ductal adenocarcinoma: Pan and colleagues demonstrated using scRNA-seq of pancreatic ductal carcinomas that MEG3 expression was significantly enriched in CAFs of primary tumors, and MEG3 expression was significantly associated with epithelial-mesenchymal transition signatures [80].